Background: The contemporary health care environment is complex, with mounting pressures to perform greater procedural volumes with less support staff to minimize costs and to maximize efficiency. This report details an analysis of routine endovascular procedures performed in a hybrid operating room with dedicated vascular support staff during daytime hours compared with similar cases performed after hours with general operating room staff.
Background: Subclavian artery revascularization is frequently performed in the setting of thoracic endovascular aortic repair (TEVAR) for a variety of indications ranging from prophylactic prevention of upper extremity and spinal cord ischemia to preservation of hemodialysis access or left internal mammary artery coronary artery bypass graft. Despite this, there is little information on the short-and long-term outcomes of patients undergoing carotid to subclavian artery bypass. We sought to define the outcomes associated with this procedure.
Methods: Patients undergoing carotid-subclavian bypass in conjunction with TEVAR between June 2005 and September 2016 were retrospectively identified from a prospectively maintained, single-center aortic surgery database. Categorical and continuous variables were compared using c 2 and Wilcoxon rank sum tests, respectively. The 30-day outcomes specific to the carotid-subclavian bypass procedure were analyzed, including nerve injury, bleeding complications, and local vascular complications. All preoperative and postoperative chest radiographs were carefully analyzed to assess for hemidiaphragm elevation indicative of phrenic nerve palsy. Long-term outcomes included primary graft patency and anastomotic complications.
Results: Of 579 patients undergoing TEVAR during this time interval, 114 patients (20%) underwent concomitant carotid-subclavian bypass. The cohort was 39% female (n ¼ 44), with a mean age of 65 6 14 years. The majority of conduits were 8-mm polytetrafluoroethylene grafts (n ¼ 107 [92.2%]), with a minority being reversed saphenous vein grafts (n ¼ 4 [3.5%]). The bypass procedure was done concomitantly at the time of TEVAR in 90.4% (n ¼ 103) of cases. The short-term complication rate attributed specifically to the carotid-subclavian bypass was 21% (n ¼ 24). These complications included neck hematoma requiring re-exploration in 0.9% (n ¼ 1), recurrent laryngeal nerve palsy in 5.3% (n ¼ 6), axillary nerve palsy in 1.8% (n ¼ 2), and phrenic nerve palsy in 13.2% (n ¼ 15) of patients. The 30-day all-cause mortality rate was 5.3% (n ¼ 6), and the rate of permanent paraparesis or paraplegia was 0.9% (n ¼ 1). Of the operative survivors (n ¼ 108), follow-up imaging of the bypass graft was available in 84% (n ¼ 96) of patients. Actuarial primary graft patency was 97% at 10 years (Fig) . There were three patients (2.5%) with bypass graft occlusions, two of which were clinically silent and detected in follow-up imaging. The third was detected because of the symptoms of subclavian steal and required repeated revascularization. Two patients (1.8%) developed a late anastomotic pseudoaneurysm requiring either endovascular (n ¼ 1) or surgical (n ¼ 1) intervention.
Conclusions: Carotid-subclavian bypass for revascularization of the subclavian artery performed in the setting of TEVAR is durable, although the true complication rate is likely to be higher than generally reported in the literature because of a not insignificant rate of phrenic nerve palsy. These data should serve well as "gold standard" comparison data for emerging branch graft devices. Background: We proposed to assess the gender-based differences in age, body mass index (BMI), race, comorbidities, abdominal aortic Abstracts
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January 2018 aneurysm (AAA) diameter, aortic neck, and iliac arteries in patients undergoing endovascular aneurysm repair (EVAR) and to evaluate the impact of these variables on survival after EVAR. Methods: Between 2002 and 2009, there were 464 EVAR procedures performed at our institution, and 336 patients had an adequate digital preoperative computed tomography scan of the AAA available and complete descriptive and survival data. The scans were sent to a core imaging laboratory (M2S, Lebanon, NH), which extracted aortic neck length, diameter, angulation, and calcification; iliac length, tortuosity, angulation, and calcification; and AAA diameter. These measurements were returned in a spreadsheet to which we added the patient's information. Mortality of the patients was assessed using the Social Security Death Master File. Survival time was defined by number of days between date of surgery and date of death. Kaplan-Meier estimation was used to generate survival curves. Multivariable Cox proportional hazards regression model with restricted cubic splines (with three knots) on continuous covariates was performed to assess association between 5-year mortality and patients' sex while adjusting for other covariates (age, race, BMI, tobacco use history, comorbidities, aortic neck, iliac artery, and AAA variables).
Results: There were 278 men and 58 women in the total group. The average age for the men was 73 years compared with 77 years for the women (P ¼ .0005). Whites accounted for 255 (91.7%) of the men and 49 (84.5%) of the women (P ¼ .87). The average BMI was 25.2 in the men and 23.1 in the women (P ¼ .006). The female and male groups were comparable for comorbidities except for coronary artery disease, for which men had a higher frequency of coronary artery bypass grafting (P ¼ .02) and percutaneous coronary intervention (P ¼ .03). The anatomic differences are detailed in Table 1 . Men (43.5%) were more likely than women (22.4%) to have EVAR performed within the device instructions for use guidelines (P ¼ .0002). The 5-year survival in women who were treated by EVAR was 49% compared with 73% in men. In multivariate analysis, sex was not statistically significant. Increase in age, iliac artery length, congestive heart failure, dialysis, and BMI <25 kg/m 2 or >30 kg/ m 2 were significantly associated with shorter survival (Table 2) . Conclusions: Significant anatomic differences exist between men and women undergoing EVAR. Women present at an older age but with similar AAA diameter to that of men. Women have more hostile anatomy in general and have a significantly reduced survival than men after EVAR. After controlling for comorbidities, aortic neck, and iliac artery anatomy, gender does not appear to be an independent predictor for survival.
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Background: Anemia is associated with increased cardiac adverse events during the early postoperative period because of high physiologic stress and increased cardiac demand. The aim of this study was to assess the surgical outcomes and prognostic implications of anemia in abdominal aortic aneurysm (AAA) patients.
Methods: A retrospective analysis of all patients who underwent open aortic repair (OAR) or endovascular aneurysm repair (EVAR) in the Vascular Quality Initiative database (2008-2017) was performed. We excluded patients with preoperative polycythemia, patients with ruptured aneurysms, and patients transfused with >4 units of packed red blood cells to avoid inclusion of patients with blood loss anemia. The primary outcome was in-hospital major adverse cardiac events (MACEs), defined as the occurrence of myocardial infarction, stroke, or death. Based on the location of knots (significant change in slopes) in the cubic spline model, hemoglobin levels were categorized into three groups: severe anemia (<10 g/dL), mild anemia (10-12 g/dL in women and 10-13 g/dL in men), and no anemia (>12 g/dL and >13 g/dL in women and men, respectively). Multivariate logistic regression analysis adjusting for patients' demographics, symptomatic status, comorbidities (diabetes, hypertension, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease), and preoperative medications as well as for aneurysm diameter, intraoperative blood loss, and concomitant procedures was performed.
Results: A total of 34,397 patients were included. Of those, 28.5% had mild anemia and 4.3% had severe anemia. In both OAR (n ¼ 6112) and EVAR (n ¼ 28,285), patients with severe anemia had significantly higher rates of mortality, myocardial infarction, MACE, renal and respiratory complications, and reoperation compared with patients with mild or no anemia. They also had longer operative times as well as intensive care unit and hospital stay (Table) . In addition, EVAR patients with severe anemia also had higher rates of acute congestive heart failure, dysrhythmia, and bowel and leg ischemia compared with patients with mild or no anemia. On multivariate analysis, severe anemia in patients undergoing OAR was associated with 80% higher odds of in-hospital MACE (odds ratio [OR], 1.83; 95% confidence interval [CI], 1.32-2.53; P < .001) and almost double the odds of 30-day mortality (OR, 1.91; 95% CI, 1.10-3.29; P ¼ .02). In EVAR, severe anemia was associated with double the risk of MACE (OR, 1.98; 95% CI, 1.43-2.74) and almost threefold the risk of 30-day mortality (OR, 2.92; 95% CI, 1.86-4.58; P < .001), whereas mild anemia increased the odds of MACE by 40% (OR, 1.37; 95% CI, 1.09-1.73) and 30-day mortality by 56% (OR, 1.56; 95% CI, 1.12-2.15). Interestingly, preoperative blood transfusion in mildly anemic patients undergoing EVAR was associated with 2.3 times the odds of MACE (OR, 2.3; 95% CI, 1.39-3.75; P < .01).
Conclusions: Severe anemia is an independent predictor of MACE and 30-day mortality after AAA repair. Blood transfusion for mild anemia before EVAR significantly increases adverse cardiac events. Thus, medical management of anemia in these patients might be a better option than transfusion. These findings highlight the need to incorporate anemia into the preoperative risk assessment of patients undergoing AAA repair and to identify a safe hemoglobin threshold to transfuse patients. Proximal aortic neck diameter 15 mm inferiorly 24.2 6 3.5 24.6 6 3.4 22.4 6 3.6 <.0001
Aortic neck calcification score 0.6 6 0.8 0.6 6 0.8 0.6 6 0.7 .76
Aortic neck length 20.9 6 12.6 21.9 6 12.5 16.1 6 11.9 .001
Iliac artery length 60.2 6 18.0 61.2 6 17.8 55.3 6 18.4 .01
Left common iliac artery diameter 14.0 6 4.0 14.5 6 4.1 11.2 6 1.8 <.0001
Right common iliac artery diameter 15.2 6 5.4 15.9 6 5.6 11.9 6 2.2 <.0001
Iliac artery angle 114.1 6 14.6 113.5 6 14.6 117.1 6 14.6 .08 BMI, Body mass index; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease.
